These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 18410628)

  • 21. Mycophenolate mofetil treatment for primary glomerular diseases.
    Levin ML
    Kidney Int; 2002 Oct; 62(4):1475. PubMed ID: 12234325
    [No Abstract]   [Full Text] [Related]  

  • 22. Mycophenolate mofetil treatment of a patient with hyperglobulinemic purpura.
    Waldman MA; Callen JP
    J Am Acad Dermatol; 2004 Oct; 51(4):667-9. PubMed ID: 15455483
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of atopic dermatitis with mycophenolate mofetil.
    Hansen ER; Buus S; Deleuran M; Andersen KE
    Br J Dermatol; 2000 Dec; 143(6):1324-6. PubMed ID: 11122047
    [No Abstract]   [Full Text] [Related]  

  • 24. Mycophenolate mofetil: implications for the treatment of glomerular disease.
    Badid C; Desmouliere A; Laville M
    Nephrol Dial Transplant; 2001 Sep; 16(9):1752-6. PubMed ID: 11522852
    [No Abstract]   [Full Text] [Related]  

  • 25. Is mycophenolate mofetil a new alternative in the treatment of inflammatory bowel disease?
    Present DH
    Gut; 1999 May; 44(5):592-3. PubMed ID: 10205187
    [No Abstract]   [Full Text] [Related]  

  • 26. [Mycophenolate mofetil--a new therapeutic agent for chronic autoimmune diseases].
    Harboe E; Gøransson L; Wildhagen K; Omdal R
    Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1650-2. PubMed ID: 15976831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety profile of mycophenolate mofetil.
    Basara N; Fauser AA
    Bone Marrow Transplant; 2000 Dec; 26(12):1362-3. PubMed ID: 11223981
    [No Abstract]   [Full Text] [Related]  

  • 28. Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide.
    Glicklich D; Acharya A
    Am J Kidney Dis; 1998 Aug; 32(2):318-22. PubMed ID: 9708620
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relentless placoid chorioretinitis associated with central nervous system lesions treated with mycophenolate mofetil.
    Yeh S; Lew JC; Wong WT; Nussenblatt RB
    Arch Ophthalmol; 2009 Mar; 127(3):341-3. PubMed ID: 19273806
    [No Abstract]   [Full Text] [Related]  

  • 30. Mycophenolate mofetil.
    Surjushe A; Saple DG
    Indian J Dermatol Venereol Leprol; 2008; 74(2):180-4. PubMed ID: 18388396
    [No Abstract]   [Full Text] [Related]  

  • 31. [Extracorporeal photopheresis--treatment option in scleromyxedema?].
    Durani BK; Bock M; Näher H
    Hautarzt; 2001 Oct; 52(10 Pt 2):938-41. PubMed ID: 11715388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
    Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Bonsmann G; Luger TA
    Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Benefits of mycophenolate mofetil in non-transplant kidney diseases].
    Parotte MC; Bovy C; Krzesinski JM
    Rev Med Suisse; 2007 Aug; 3(122):1899-901, 1903-5. PubMed ID: 17896664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease.
    Liossis SN; Bounas A; Andonopoulos AP
    Rheumatology (Oxford); 2006 Aug; 45(8):1005-8. PubMed ID: 16490756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Generalized morphea successfully treated with extracorporeal photochemotherapy (ECP).
    Pileri A; Raone B; Raboni R; Giudice V; Patrizi A
    Dermatol Online J; 2014 Jan; 20(1):21258. PubMed ID: 24456961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycophenolate mofetil in the treatment of ocular inflammation in ANCA-associated vasculitis.
    Yalçindağ FN; Amer R; Forrester JV
    J Ocul Pharmacol Ther; 2008 Apr; 24(2):249-54. PubMed ID: 18321200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of pemphigus vulgaris with mycophenolate mofetil as a steroid-sparing agent.
    Esmaili N; Chams-Davatchi C; Valikhani M; Farshidfar F; Parvaneh N; Tamizifar B
    Eur J Dermatol; 2008; 18(2):159-64. PubMed ID: 18424375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease.
    Swigris JJ; Olson AL; Fischer A; Lynch DA; Cosgrove GP; Frankel SK; Meehan RT; Brown KK
    Chest; 2006 Jul; 130(1):30-6. PubMed ID: 16840379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mycophenolate mofetil as an effective corticosteroid-sparing therapy for recalcitrant dermatomyositis.
    Edge JC; Outland JD; Dempsey JR; Callen JP
    Arch Dermatol; 2006 Jan; 142(1):65-9. PubMed ID: 16415388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bullous pemphigoid treated with mycophenolate mofetil.
    Böhm M; Beissert S; Schwarz T; Metze D; Luger T
    Lancet; 1997 Feb; 349(9051):541. PubMed ID: 9048797
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.